Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Rapport Therapeutics (RAPP) Return on Assets (2024 - 2026)

Rapport Therapeutics (RAPP) has 3 years of Return on Assets data on record, last reported at 0.0% in Q1 2026.

  • On a quarterly basis, Return on Assets changed 0.0% to 0.0% in Q1 2026 year-over-year; TTM through Mar 2026 was 0.0%, a 0.0% change, with the full-year FY2025 number at 0.0%, changed 0.0% from a year prior.
  • Return on Assets reached 0.0% in Q1 2026 per RAPP's latest filing, roughly flat from 0.0% in the prior quarter.
  • Over the last five years, Return on Assets for RAPP hit a ceiling of 0.0% in Q3 2024 and a floor of 0.0% in Q2 2025.
  • A 3-year average of 0.0% and a median of 0.0% in 2024 define the central range for Return on Assets.
  • On a YoY basis, Return on Assets climbed as much as 0bps in 2025 and fell as far as 0bps in 2025.
  • Tracing RAPP's Return on Assets over 3 years: stood at 0.0% in 2024, then rose by 3bps to 0.0% in 2025, then rose by 0bps to 0.0% in 2026.
  • Business Quant data shows Return on Assets for RAPP at 0.0% in Q1 2026, 0.0% in Q4 2025, and 0.0% in Q3 2025.